Exide Industries witnessed a 13.66% dip in consolidated profit for the September quarter, despite a rise in revenue. The company’s profits were impacted by increased expenses, even as demand in sectors like two-wheeler, four-wheeler, and industrial-UPS remained strong.
Gland Pharma shares zoom 12% post Q2 results; Kotak upgrades on limited downside
Gland Pharma Share Price: Gland Pharma shares rose 12% despite a 15.7% YoY profit decline in Q2. Kotak upgraded the stock to ‘Reduce’ with a